Exact Mass: 578.2192834
Exact Mass Matches: 578.2192834
Found 167 metabolites which its exact mass value is equals to given mass value 578.2192834
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
gosspyl acetate
R-(-)-Gossypol Acetic Acid is the orally bioavailable solvate of the R-(-) enantiomer of gossypol and acetic acid with potential antineoplastic activity. As a BH3 mimetic, R-(-)-gossypol binds to the hydrophobic surface binding groove BH3 of the anti-apoptotic proteins Bcl-2 and Bcl-xL, blocking their heterodimerization with pro-apoptotic members of the Bcl-2 family of proteins such as Bad, Bid, and Bim; this may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. Racemic gossypol is a polyphenolic compound isolated from cottonseed. Gossypol acetic acid ((±)-Gossypol-acetic acid) binds to Bcl-xL protein and Bcl-2 protein with Kis of 0.5-0.6 μM and 0.2-0.3 mM, respectively. Gossypol acetic acid ((±)-Gossypol-acetic acid) binds to Bcl-xL protein and Bcl-2 protein with Kis of 0.5-0.6 μM and 0.2-0.3 mM, respectively.
(1S,4aS,6R,9S,9aS)-7-{2-[(3R)-2,3-dihydro-3-hydroxy-2-oxo-1H-indol-3-yl]ethyl}-1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,8,9,9a-octahydro-6,9-epoxypyrano[3,4-d]azepine-4-carboxylic acid methyl ester|anthocephalusine A
(aR)-3,3-Dimethyl-7,7,9,9-tetramethoxy-3,3,4,4-tetrahydro-5,6-bi[1H-naphtho[2,3-c]pyran]-4,4,10,10-tetraol
phenethyl alcohol 8-O-beta-D-glucopyranosyl-(1->2)-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
kansanoside A|phenylethyl-beta-D-glucopyranosyl-(1->2)-[beta-D-xylopyranosyl-(1->6)]-beta-D-galactopyranoside
gosspyl acetate
R-(-)-Gossypol Acetic Acid is the orally bioavailable solvate of the R-(-) enantiomer of gossypol and acetic acid with potential antineoplastic activity. As a BH3 mimetic, R-(-)-gossypol binds to the hydrophobic surface binding groove BH3 of the anti-apoptotic proteins Bcl-2 and Bcl-xL, blocking their heterodimerization with pro-apoptotic members of the Bcl-2 family of proteins such as Bad, Bid, and Bim; this may result in the inhibition of tumor cell proliferation and the induction of tumor cell apoptosis. Racemic gossypol is a polyphenolic compound isolated from cottonseed. Gossypol acetic acid ((±)-Gossypol-acetic acid) binds to Bcl-xL protein and Bcl-2 protein with Kis of 0.5-0.6 μM and 0.2-0.3 mM, respectively. Gossypol acetic acid ((±)-Gossypol-acetic acid) binds to Bcl-xL protein and Bcl-2 protein with Kis of 0.5-0.6 μM and 0.2-0.3 mM, respectively.
(3S,4S)-5-[(3S,4S)-4,10-dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol
(3S,4S)-5-[(3S,4S)-4,10-dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol
(3S,4S)-5-[(3S,4S)-4,10-dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol [IIN-based on: CCMSLIB00000849079]
(3S,4S)-5-[(3S,4S)-4,10-dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol [IIN-based: Match]
(3S,4S)-5-[(3S,4S)-4,10-dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol_major
(3S,4S)-5-[(3S,4S)-4,10-dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol_67.3\\%
Cys Asp Arg Trp
Cys Asp Trp Arg
Cys Phe Phe Tyr
Cys Phe Tyr Phe
Cys Arg Asp Trp
Cys Arg Trp Asp
Cys Trp Asp Arg
Cys Trp Arg Asp
Cys Tyr Phe Phe
Asp Cys Arg Trp
Asp Cys Trp Arg
Asp Met Gln Trp
C25H34N6O8S (578.2158724000001)
Asp Met Trp Gln
C25H34N6O8S (578.2158724000001)
Asp Gln Met Trp
C25H34N6O8S (578.2158724000001)
Asp Gln Trp Met
C25H34N6O8S (578.2158724000001)
Asp Arg Cys Trp
Asp Arg Trp Cys
Asp Trp Cys Arg
Asp Trp Met Gln
C25H34N6O8S (578.2158724000001)
Asp Trp Gln Met
C25H34N6O8S (578.2158724000001)
Asp Trp Arg Cys
Glu His Met Tyr
C25H34N6O8S (578.2158724000001)
Glu His Tyr Met
C25H34N6O8S (578.2158724000001)
Glu Met His Tyr
C25H34N6O8S (578.2158724000001)
Glu Met Asn Trp
C25H34N6O8S (578.2158724000001)
Glu Met Trp Asn
C25H34N6O8S (578.2158724000001)
Glu Met Tyr His
C25H34N6O8S (578.2158724000001)
Glu Asn Met Trp
C25H34N6O8S (578.2158724000001)
Glu Asn Trp Met
C25H34N6O8S (578.2158724000001)
Glu Trp Met Asn
C25H34N6O8S (578.2158724000001)
Glu Trp Asn Met
C25H34N6O8S (578.2158724000001)
Glu Tyr His Met
C25H34N6O8S (578.2158724000001)
Glu Tyr Met His
C25H34N6O8S (578.2158724000001)
Phe Cys Phe Tyr
Phe Cys Tyr Phe
Phe Phe Cys Tyr
Phe Phe Tyr Cys
Phe Tyr Cys Phe
Phe Tyr Phe Cys
His Glu Met Tyr
C25H34N6O8S (578.2158724000001)
His Glu Tyr Met
C25H34N6O8S (578.2158724000001)
His Met Glu Tyr
C25H34N6O8S (578.2158724000001)
His Met Tyr Glu
C25H34N6O8S (578.2158724000001)
His Tyr Glu Met
C25H34N6O8S (578.2158724000001)
His Tyr Met Glu
C25H34N6O8S (578.2158724000001)
Met Asp Gln Trp
C25H34N6O8S (578.2158724000001)
Met Asp Trp Gln
C25H34N6O8S (578.2158724000001)
Met Glu His Tyr
C25H34N6O8S (578.2158724000001)
Met Glu Asn Trp
C25H34N6O8S (578.2158724000001)
Met Glu Trp Asn
C25H34N6O8S (578.2158724000001)
Met Glu Tyr His
C25H34N6O8S (578.2158724000001)
Met His Glu Tyr
C25H34N6O8S (578.2158724000001)
Met His Tyr Glu
C25H34N6O8S (578.2158724000001)
Met Asn Glu Trp
C25H34N6O8S (578.2158724000001)
Met Asn Trp Glu
C25H34N6O8S (578.2158724000001)
Met Gln Asp Trp
C25H34N6O8S (578.2158724000001)
Met Gln Trp Asp
C25H34N6O8S (578.2158724000001)
Met Trp Asp Gln
C25H34N6O8S (578.2158724000001)
Met Trp Glu Asn
C25H34N6O8S (578.2158724000001)
Met Trp Asn Glu
C25H34N6O8S (578.2158724000001)
Met Trp Gln Asp
C25H34N6O8S (578.2158724000001)
Met Tyr Glu His
C25H34N6O8S (578.2158724000001)
Met Tyr His Glu
C25H34N6O8S (578.2158724000001)
Asn Glu Met Trp
C25H34N6O8S (578.2158724000001)
Asn Glu Trp Met
C25H34N6O8S (578.2158724000001)
Asn Met Glu Trp
C25H34N6O8S (578.2158724000001)
Asn Met Trp Glu
C25H34N6O8S (578.2158724000001)
Asn Trp Glu Met
C25H34N6O8S (578.2158724000001)
Asn Trp Met Glu
C25H34N6O8S (578.2158724000001)
Gln Asp Met Trp
C25H34N6O8S (578.2158724000001)
Gln Asp Trp Met
C25H34N6O8S (578.2158724000001)
Gln Met Asp Trp
C25H34N6O8S (578.2158724000001)
Gln Met Trp Asp
C25H34N6O8S (578.2158724000001)
Gln Trp Asp Met
C25H34N6O8S (578.2158724000001)
Gln Trp Met Asp
C25H34N6O8S (578.2158724000001)
Arg Cys Asp Trp
Arg Cys Trp Asp
Arg Asp Cys Trp
Arg Asp Trp Cys
Arg Trp Cys Asp
Arg Trp Asp Cys
Trp Cys Asp Arg
Trp Cys Arg Asp
Trp Asp Cys Arg
Trp Asp Met Gln
C25H34N6O8S (578.2158724000001)
Trp Asp Gln Met
C25H34N6O8S (578.2158724000001)
Trp Asp Arg Cys
Trp Glu Met Asn
C25H34N6O8S (578.2158724000001)
Trp Glu Asn Met
C25H34N6O8S (578.2158724000001)
Trp Met Asp Gln
C25H34N6O8S (578.2158724000001)
Trp Met Glu Asn
C25H34N6O8S (578.2158724000001)
Trp Met Asn Glu
C25H34N6O8S (578.2158724000001)
Trp Met Gln Asp
C25H34N6O8S (578.2158724000001)
Trp Asn Glu Met
C25H34N6O8S (578.2158724000001)
Trp Asn Met Glu
C25H34N6O8S (578.2158724000001)
Trp Gln Asp Met
C25H34N6O8S (578.2158724000001)
Trp Gln Met Asp
C25H34N6O8S (578.2158724000001)
Trp Arg Cys Asp
Trp Arg Asp Cys
Tyr Cys Phe Phe
Tyr Glu His Met
C25H34N6O8S (578.2158724000001)
Tyr Glu Met His
C25H34N6O8S (578.2158724000001)
Tyr Phe Cys Phe
Tyr Phe Phe Cys
Tyr His Glu Met
C25H34N6O8S (578.2158724000001)
Tyr His Met Glu
C25H34N6O8S (578.2158724000001)
Tyr Met Glu His
C25H34N6O8S (578.2158724000001)
Tyr Met His Glu
C25H34N6O8S (578.2158724000001)
Vardenafil HCl Trihydrate
D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Ananolignan K
A lignan with a dibenzocyclooctadiene skeleton isolated from Kadsura ananosma
N-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide
N-[[(4S,5R)-8-(1-cyclohexenyl)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide
N-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide
N-[[(4R,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide
2-[(2R,4aR,12aS)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
N-[[(4S,5S)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-3-methoxy-N-methylbenzenesulfonamide
2-[(2S,4aR,12aR)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,4aS,12aR)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,4aS,12aS)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,4aS,12aR)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,4aR,12aS)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,4aR,12aR)-5-methyl-8-[(4-methylphenyl)sulfonylamino]-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
Cyclo(Arg-Gly-Asp-D-Phe-Cys)
Cyclo(Arg-Gly-Asp-D-Phe-Cys) (Cyclo RGDfC), a cyclic RGD peptide which has high affinity to αvβ3, can disrupt cell integrin interactions. Cyclo(Arg-Gly-Asp-D-Phe-Cys) inhibits pluripotent marker expression in embryonic stem cells (ESCs) and the tumorigenic potential of mESCs in vivo. Cyclo(Arg-Gly-Asp-D-Phe-Cys) can be used in the research of tumors[1].